BlackRock’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,500
Closed -$11.6M 5886
2026
Q1
$11.6M Buy
+23,500
New +$12.8M ﹤0.01% 3403
2024
Q2
Sell
-700
Closed -$407K 5350
2024
Q1
$407K Buy
+700
New +$393K ﹤0.01% 4426
2021
Q4
Sell
-166,600
Closed -$95.2M 5858
2021
Q3
$95.2M Buy
+166,600
New +$91.4M ﹤0.01% 2250

Other funds holding TMO

BlackRock's TMO Position: Q2 2026 in Review

BlackRock increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, buying an estimated $236M and bringing the position to 30,919,632 shares worth $15.5B. The position accounts for 0.23% of the portfolio, ranked #67.

BlackRock first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.7B in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BlackRock held 30,919,632 shares of Thermo Fisher Scientific worth $15.5B as of Q2 2026.
  • BlackRock bought 492,440 Thermo Fisher Scientific shares in Q2 2026, an estimated $236M.
  • Thermo Fisher Scientific made up 0.23% of BlackRock's portfolio in Q2 2026, its #67 holding.
  • BlackRock first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Thermo Fisher Scientific position peaked at $20.7B in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.